Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.3.1.28 (
chloramphenicol acetyltransferase
)
5,100
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
ZO-2
is a membrane-associated guanylate kinase (MAGUK) protein present at the tight junction (TJ) of epithelial cells. While confluent monolayers have
ZO-2
at their cellular borders, sparse cultures conspicuously show
ZO-2
at the nuclei. To study the role of nuclear
ZO-2
, we tested by pull-down assays and gel shift analysis the interaction between
ZO-2
GST fusion proteins and different transcription factors. We identified the existence of a specific interaction of
ZO-2
with Fos, Jun and C/EBP (CCAAT/enhancer binding protein). To analyze if this association is present "in vivo", we performed immunoprecipitation and immunolocalization experiments, which revealed an interaction of
ZO-2
with Jun, Fos and C/EBP not only at the nucleus but also at the TJ region. To test if the association of
ZO-2
with AP-1 (activator protein-1) modulates gene transcription, we performed reporter gene assays employing
chloramphenicol acetyltransferase
(
CAT
) constructs with promoters under the control of AP-1 sites. We observed that the co-transfected
ZO-2
down-regulates
CAT
expression in a dose-dependent manner. Since
ZO-2
is a multidomain protein, we proceeded to determine which region of the molecule is responsible for the modulation of gene expression, and observed that both the amino and the carboxyl domains are capable of inhibiting gene transcription.
...
PMID:The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. 1472 May 6